drugset / Trial / NCT04304768

Opioid, HIV and Immune System

NCT04304768

Phase 4 Active not recruiting 400 enrolled University of Miami
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this research is to evaluate blood samples from HIV infected and non-HIV infected people opioid and non opioid users to understand how opioid affect the immune responses (body defenses against infection) to the flu vaccine.

Timeline

Start
2020-11-18
Primary completion
2027-01-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine 0.5 ml Intramuscular